Akero Therapeutics News

Akero Therapeutics | 8-K: Current report

Jun 13 05:27

Akero Therapeutics | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers

May 11 05:00

Akero Therapeutics | DEF 14A: Definitive information statements

Apr 27 04:37

Akero Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Apr 17 04:31

Akero Therapeutics | 8-K: Current report

Mar 19 04:36

Akero Therapeutics | 8-K: Current report

Mar 7 06:30

Akero Therapeutics | 8-K: Current report

Mar 4 21:00

Akero Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Mar 1 05:49

Akero Therapeutics | 8-K: Current report

Dec 18, 2023 20:08

Akero Therapeutics | 8-K: Current report

Oct 10, 2023 20:04

Akero Therapeutics | 8-K: Current report

Jun 27, 2023 04:02

Akero Therapeutics | 8-K: Current report

Jun 5, 2023 20:05

Akero Therapeutics | 8-K: Current report

May 18, 2023 05:01

Akero Therapeutics | DEF 14A: Definitive proxy statements

Apr 29, 2023 04:39

Akero Therapeutics | 8-K: Current report

Mar 30, 2023 05:20

Akero Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Mar 18, 2023 04:36

Akero Therapeutics | 8-K: Current report

Mar 17, 2023 20:43

Akero Therapeutics | 8-K: Current report

Sep 17, 2022 04:02

Akero Therapeutics | 8-K: Current report

Sep 13, 2022 21:07

Akero Therapeutics | 8-K: Current report

Jun 16, 2022 19:14